Archives
-
A 83-01 ALK-5 Inhibitor for Organoids
2026-09-19
A 83-01 enables controlled interrogation of TGF-β signaling in intestinal organoids, EMT models, and proliferation assays without treating self-renewal and differentiation as fixed endpoints. This workflow-focused guide connects pathway inhibition, practical dosing, assay controls, and troubleshooting to the tunable organoid strategy reported in recent research.
-
NF449 and Platelet P2X1 Receptor Inhibition
2026-09-18
The reference study established NF449 as a preferential antagonist of platelet P2X1 receptors and used complementary human platelet and mouse thrombosis models to define its functional effects. Its dose-dependent selectivity reduced platelet activation and thrombus formation while preserving bleeding time at the lower exposure, providing a mechanistic framework for targeted antithrombotic research.
-
(-)-Blebbistatin for Mechanomemory Assays
2026-09-18
Use (-)-Blebbistatin as a reversible, cell-permeable non-muscle myosin II inhibitor to separate actomyosin force transmission from upstream mechanical stimulation. This workflow connects intermittent-stress mechanomemory, YAP imaging, cytoskeletal dynamics research, and practical assay troubleshooting.
-
VE-822 ATR Inhibitor: Practical Research Workflows
2026-09-17
VE-822 is a potent ATR inhibitor for converting replication stress into a measurable vulnerability in radiation and gemcitabine studies, with particular value in pancreatic ductal adenocarcinoma models. This guide combines compound handling, combination-treatment design, DNA-damage readouts, and a cautious extension into nuclear cGAS and LINE-1 research.
-
Cyanine 3 Tyramide for Oxytocin Circuit Mapping
2026-09-17
Cyanine 3 Tyramide enables sensitive spatial analysis of oxytocin-related signaling in brain tissue. This article explains how TSA fluorescence can improve assay decisions for receptor mapping, circuit interpretation, and validation of developmental stress models.
-
Cy3-UTP for Fluorescent RNA Labeling
2026-09-16
Cy3-UTP is a Cy3-modified uridine triphosphate for fluorescent RNA production by in vitro transcription. It supports sensitive RNA visualization and detection, but fluorescence alone does not establish RNA delivery, endosomal escape, or biological activity.
-
BCECF-AM Maps V-ATPase-Linked pH in Autophagy
2026-09-16
BCECF-AM enables ratiometric intracellular pH measurement that can connect vacuolar acidification to autophagic vesicle degradation. This article translates the SINAT–VAB1 findings in Arabidopsis into a practical, control-driven assay strategy while clarifying what cytosolic pH data can—and cannot—prove.
-
TMEM16F Scrambling Links Ferroptosis to Tumor Immunity
2026-09-15
Yang et al. identify TMEM16F-mediated plasma-membrane phospholipid scrambling as a late-stage suppressor of ferroptosis. Loss of this membrane response increases lytic death and danger signaling, while combining scrambling inhibition with PD-1 blockade promotes tumor immune rejection.
-
Mechanical Stress, Cytoskeleton, and Autophagy
2026-09-15
The reference study shows that compressive mechanical stress induces autophagy through a cytoskeleton-dependent process in human cell lines. Its central advance is the distinction between microfilaments, which are required for changes in autophagosome abundance, and microtubules, which provide an auxiliary contribution.
-
3X (DYKDDDDK) Peptide for Assay Workflows
2026-09-14
Learn how 3X (DYKDDDDK) Peptide, SKU A6001, can strengthen expression checks, purification, and mechanistic interpretation around cell viability, proliferation, and cytotoxicity studies. This scenario-based guide separates validated product specifications from workflow recommendations so researchers can improve assay traceability without treating an epitope peptide as a viability reagent.
-
Cy3-UTP as a Spatial RNA Assay Tool
2026-09-14
Cy3-UTP enables bright, trackable RNA production for imaging and interaction experiments. This article explains how to use Cy3-modified uridine triphosphate to interrogate RNA organization, drawing on new insights into Alu RNA and nuclear speckles while emphasizing controls that preserve biological interpretation.
-
MitMAB: Causal Logic for Organoid Uptake
2026-09-13
MitMAB provides a mechanistic way to test dynamin-dependent uptake in polarized intestinal organoids. This article explains how to interpret inhibitor results alongside the region- and polarity-specific findings of a porcine milk extracellular vesicle study.
-
PreScission Protease for Nuclear Biology
2026-09-12
PreScission Protease enables precise fusion protein tag cleavage before localization and chromatin assays. This article explains how HRV 3C protease can improve construct interpretation while connecting protein purification decisions to evidence from Drosophila Keap1–lamin research.
-
Carrier-Platin and the ROS Storm in Cancer Cells
2026-09-11
The Biomaterials study introduces carrier-platin, a poly(amino acid) formulation containing ultrasmall platinum nanoparticles that produces a rapid intracellular ROS burst. The resulting cancer-cell death occurs within approximately 30 minutes, is distinct from apoptosis and ferroptosis, and remains independent of DNA damage, suggesting a potential strategy for drug-resistant tumors.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-09-11
A 2025 mouse study reports that thymoquinone reduces doxorubicin-induced cardiac injury, with protection associated with improved cardiac function, redox balance, mitochondrial structure, and Nrf2/HO-1 signaling. The findings position thymoquinone as a useful preclinical probe for investigating oxidative stress and ferroptosis-related mechanisms, while pathway causality and clinical translation remain unresolved.